Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD

키워드

참고문헌 (12)

1. Lazarus JV, "Reply : A multi-society delphi consensus statement on new fatty liver disease nomenclature", Hepatology (2023)[DOI]
2. El-Serag HB, "Update on the epidemiology of gastro-oesophageal reflux disease : a systematic review", Gut, 63, pp.871~880 (2014)
3. Jansson C, "Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a populationbased study", Aliment Pharmacol Ther, 26, pp.683~691 (2007)
4. Fuller G, "PRISM, a patient-reported outcome instrument, accurately measures symptom change in refractory gastroesophageal reflux disease", Dig Dis Sci, 62, pp.593~606 (2017)
5. Fujiwara Y, "Association between dinner-to-bed time and gastro-esophageal reflux disease", Am J Gastroenterol, 100, pp.2633~2636 (2005)
6. Mohammadi M, "Is metabolic syndrome considered to be a risk factor for gastroesophageal reflux disease(non-erosive or erosive esophagitis)? : A systematic review of the evidence", Iran Red Crescent Med J, 18, pp.e30363~ (2016)
7. Tomeno W, "Complications of non-alcoholic fatty liver disease in extrahepatic organs", Diagnostics(Basel), 10, pp.912~ (2020)
8. Yi M, "Extrahepatic morbidities and mortality of NAFLD : an umbrella review of meta-analyses", Aliment Pharmacol Ther, 56, pp.1119~1130 (2022)
9. Hagström H, "99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical", J Hepatol (2023)[DOI]
10. Yoon EL, "Waiting for the changes after the adoption of steatotic liver disease", Clin Mol Hepatol, 29, pp.844~850 (2023)
11. Kim GA, "Critical appraisal of metabolic dysfunction-associated steatotic liver disease : Implication of Janusfaced modernity", Clin Mol Hepatol, 29, pp.831~843 (2023)
12. Dent J, "Endoscopic grading of reflux oesophagitis : the past, present and future", Best Pract Res Clin Gastroenterol, 22, pp.585~599 (2008)

관련 논문AI추천